Cutaneous candidosis in immunosuppressed patients

Folia Microbiol (Praha). 2001;46(4):359-60. doi: 10.1007/BF02815627.

Abstract

One-hundred patients with candidosis of the skin, mucous membranes and nail plates (confirmed by cultivation) were examined. Topical or systemic antimycotic treatment was successful in 58 patients. After a complete evaluation, 42 patients were found to suffer from factors supporting candidosis--diabetes mellitus (12), anemia (3) and various local factors (10 patients); 27 patients showed a deficiency in cell-mediated immunity. In addition to intensive antimycotic therapy, successful treatment is affected by the actual immunity level and can be ensured by efficient immunomodulation treatment of immunodeficiency.

MeSH terms

  • Antibodies, Fungal / blood
  • Antifungal Agents / therapeutic use
  • Antigen-Antibody Complex / blood
  • Candida / classification
  • Candida / pathogenicity*
  • Candidiasis, Cutaneous / drug therapy
  • Candidiasis, Cutaneous / immunology*
  • Humans
  • Immunocompromised Host*
  • Phagocytosis
  • Risk Factors
  • T-Lymphocytes / immunology

Substances

  • Antibodies, Fungal
  • Antifungal Agents
  • Antigen-Antibody Complex